"Influential people are once again twisting the truth about vaccines for their own gain," writes Eleanor Menzin.

The European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...

If approved by the EMA, mavorixafor would be the first drug indicated for patients with WHIM syndrome in Europe, a population estimated to be approximately 1,000 people. Earlier this month X4 ...

X4 Pharmaceuticals (XFOR) announced that its Marketing Authorization Application for mavorixafor for the treatment of WHIM syndrome, a rare ...

CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...

We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...

“We hope the deal will be sustained, because lives depend on it,” he said. “Peace is the best medicine!” Qatari Prime Minister Sheikh Mohammed bin Abdulrahman announced late Wednesday that ...

Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, P. R. China Tang Center for Herbal ...

Headache Medicine: What Should You Take? Medicines can help you manage, prevent, or end headache pain. There are many different treatment options available. Some medicines relieve headache pain ...

with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP). The European Medicines Agency (EMA) drugs advisory panel has recommended the oral SGLT1/2 inhibitor as an ...

Some medicines need to be given at a certain time to make sure they are safe or work effectively. The stomach or intestinal contents can affect the absorption of some medicines. Some medicines need to ...